Skip to Main Content

Dysregulation in mGluR5 as a marker of BPD and suicide related endophenotypes

Conditions

Mental Health & Behavioral Research

Phase Pilot

What is the purpose of this trial?

This study involves the use of brain imaging (MRI and PET) to investigate a potential novel intervention target in borderline personality disorder. Participation in this study begins with a short confidential phone interview and an in-person visit for psychological and medical screening (which includes blood work and a urine drug test). All information provided is confidential. If you meet study criteria, you will be asked to return for one MRI scan and one PET scan. You will also be asked to perform some tests on a computer to assess cognitive functions such as memory and decision-making. You will be paid for each procedure you take part in.

  • Trial with
    National Institute of Mental Health (NIMH)
  • Start Date
    04/11/2019
  • End Date
    10/31/2023

I'm interested in volunteering

If you would prefer to contact a member of the Help us Discover team about this trial and other similar trials, please email helpusdiscover@yale.edu or call 877.978.8343

  • Last Updated
    07/15/2021
  • Study HIC
    #2000023168